Tatsis Ourania, EVP and Chief Regulatory and Quality Officer at Vertex Pharmaceuticals ($VRTX), sold $5.7 million in shares through 7 open market transactions in the past year. Her latest sale occurred on February 25, 2026. These sales rank her 1,754th among 11,678 insiders, trailing the average of $8.6 million and 6.4 transactions per insider. She made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | F | Common Stock | 1627 | $485.11 | 47,023.0000 | 258,000,000 | 3.34% | 0.00% |
| Feb. 25, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 260 | $486.35 | 46,763.0000 | 258,000,000 | 0.55% | 0.00% |
| Feb. 17, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | A | Common Stock | 5789 | $0.00 | 51,921.0000 | 258,000,000 | 12.55% | 0.00% |
| Feb. 17, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | F | Common Stock | 2294 | $483.75 | 49,627.0000 | 258,000,000 | 4.42% | 0.00% |
| Feb. 17, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 609 | $489.46 | 49,018.0000 | 258,000,000 | 1.23% | 0.00% |
| Feb. 18, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 368 | $473.68 | 48,650.0000 | 258,000,000 | 0.75% | 0.00% |
| Feb. 13, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 1500 | $499.99 | 46,132.0000 | 258,000,000 | 3.15% | 0.00% |
| Feb. 13, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | F | Common Stock | 3804 | $487.76 | 47,632.0000 | 258,000,000 | 7.40% | 0.00% |
| Feb. 10, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | F | Common Stock | 2140 | $468.41 | 51,902.0000 | 258,000,000 | 3.96% | 0.00% |
| Feb. 11, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 466 | $460.43 | 51,436.0000 | 258,000,000 | 0.90% | 0.00% |
| Jan. 22, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | A | Common Stock | 3883 | $0.00 | 54,042.0000 | 258,000,000 | 7.74% | 0.00% |
| Jan. 22, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | A | Common Stock | 7866 | $0.00 | 50,159.0000 | 258,000,000 | 18.60% | 0.00% |
| Jan. 7, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 4500 | $474.99 | 42,293.0000 | 258,000,000 | 9.62% | 0.00% |
| Dec. 3, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 4500 | $449.99 | 46,793.0000 | 258,600,000 | 8.77% | 0.00% |
| July 25, 2025 | Verve Therapeutics, Inc. | $VERV | Tatsis Ourania | Not found | D | Stock Option (right to buy) | 267541 | $0.00 | 0.0000 | 89,143,237 | 100.00% | 0.30% |
| July 25, 2025 | Verve Therapeutics, Inc. | $VERV | Tatsis Ourania | Not found | D | Stock Option (right to buy) | 42200 | $0.00 | 0.0000 | 89,143,237 | 100.00% | 0.05% |
| June 5, 2025 | Verve Therapeutics, Inc. | $VERV | Tatsis Ourania | Not found | A | Stock Option (right to buy) | 42200 | $0.00 | 42,200.0000 | 89,143,237 | 9999.99% | 0.05% |
| March 10, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 3242 | $499.99 | 51,239.0000 | 257,899,999 | 5.95% | 0.00% |
| March 4, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 4058 | $485.49 | 54,481.0000 | 257,899,999 | 6.93% | 0.00% |
| Feb. 26, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | F | Common Stock | 4962 | $479.61 | 59,069.0000 | 257,899,999 | 7.75% | 0.00% |
| Feb. 27, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 530 | $475.34 | 58,539.0000 | 257,899,999 | 0.90% | 0.00% |
| Feb. 24, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | F | Common Stock | 3310 | $483.28 | 64,385.0000 | 257,899,999 | 4.89% | 0.00% |
| Feb. 25, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 354 | $480.95 | 64,031.0000 | 257,899,999 | 0.55% | 0.00% |
| Feb. 14, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | F | Common Stock | 2293 | $463.46 | 67,939.0000 | 257,899,999 | 3.26% | 0.00% |
| Feb. 18, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 244 | $455.06 | 67,695.0000 | 257,899,999 | 0.36% | 0.00% |
| Feb. 12, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | A | Common Stock | 6211 | $0.00 | 70,232.0000 | 257,899,999 | 9.70% | 0.00% |
| Feb. 11, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 310 | $459.83 | 64,021.0000 | 257,899,999 | 0.48% | 0.00% |
| Feb. 10, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | F | Common Stock | 2143 | $467.98 | 64,331.0000 | 257,899,999 | 3.22% | 0.00% |
| Feb. 4, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | A | Common Stock | 10262 | $0.00 | 59,360.0000 | 257,899,999 | 20.90% | 0.00% |
| Feb. 4, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | A | Common Stock | 7114 | $0.00 | 66,474.0000 | 257,899,999 | 11.98% | 0.00% |
| June 26, 2024 | Verve Therapeutics, Inc. | $VERV | Tatsis Ourania | Not found | A | Stock Option (right to buy) | 267541 | $0.00 | 267,541.0000 | 0 | 9999.99% | 0.00% |
| June 3, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 2175 | $460.00 | 49,098.0000 | 260,500,000 | 4.24% | 0.00% |
| May 31, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 2250 | $445.00 | 51,273.0000 | 260,500,000 | 4.20% | 0.00% |
| May 30, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 2350 | $439.11 | 53,523.0000 | 260,500,000 | 4.21% | 0.00% |
| Feb. 23, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | F | Common Stock | 3309 | $431.79 | 56,158.0000 | 260,500,000 | 5.56% | 0.00% |
| Feb. 26, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 354 | $425.70 | 55,804.0000 | 260,500,000 | 0.63% | 0.00% |
| Feb. 21, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 360 | $421.77 | 59,467.0000 | 260,500,000 | 0.60% | 0.00% |
| Feb. 20, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 480 | $420.79 | 59,827.0000 | 260,500,000 | 0.80% | 0.00% |
| Feb. 20, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | F | Common Stock | 3373 | $420.58 | 60,307.0000 | 260,500,000 | 5.30% | 0.00% |
| Feb. 16, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | F | Common Stock | 4499 | $424.01 | 63,680.0000 | 260,500,000 | 6.60% | 0.00% |
| Feb. 12, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 314 | $420.24 | 68,179.0000 | 260,500,000 | 0.46% | 0.00% |
| Feb. 9, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | F | Common Stock | 2100 | $422.74 | 68,493.0000 | 260,500,000 | 2.97% | 0.00% |
| Feb. 6, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | A | Common Stock | 7866 | $0.00 | 63,479.0000 | 260,500,000 | 14.14% | 0.00% |
| Feb. 7, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | A | Common Stock | 7114 | $0.00 | 70,593.0000 | 260,500,000 | 11.21% | 0.00% |
| Feb. 6, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | A | Common Stock | 6976 | $0.00 | 55,613.0000 | 260,500,000 | 14.34% | 0.00% |